Strategic Management of Innovation in Life Science

  • Christian Schäfer

Abstract

In life science industries development projects for a new chemical entity (NCE) are generally associated with low probabilities of success compared to other industries. At start of development, an innovation project’s rate of success is only 4% to 7%, the time span of a project from start of development to the potential launch of a product being 10 years or even more. Thus, effective management of commercial risk and uncertainty becomes tremendously important.

Literatur

  1. Guthrie, N., Markland, D. (2010) Assessing Uncertainty in New-Product Forecasts Foresight: The International Journal of Applied Forecasting, Issue 16 (Winter 2010), 32–39.Google Scholar
  2. Harpum, P (2010) Portfolio, Programm, and Project Management in the Pharmaceutical and Biotechnological Industries, John Wiley & Sons, Inc, New Jersey.CrossRefGoogle Scholar
  3. Knight, F. (1921) Risk, Uncertainty and Profit: Schaffner & Marx, Houghton Mifflin, Boston.Google Scholar
  4. Sonnenberg, F.A., Beck, J.R. (1993) Markov models in medical decision making: a practical guide, Medical Decision Making, Issue 13 (4), 322–338.Google Scholar
  5. Sugiyama, S. (2007). Forecast uncertainty and Monte Carlo Simulation, Foresight: The International Journal of Applied Forecasting, Issue 6 (Spring 2007), 29–37.Google Scholar

Copyright information

© Springer Fachmedien Wiesbaden 2013

Authors and Affiliations

  • Christian Schäfer
    • 1
  1. 1.Böhringer Ingelheim GmbHIngelheim am Rhein

Personalised recommendations